Genomics Essentials in Hematologic Malignancies (GENOM)

In this activity, learn more about the role of genomics in treating hematologic malignancies and build your confidence through this interactive education activity!

Description

Genomic profiling is widely recognized as a key way to identify strategies for treating hematologic (and other) cancers. However, there is a significant disconnect between scientific evidence and hematologist/oncologist knowledge, confidence, and practice. As a wealth of new information continues to emerge, it is essential that healthcare professionals have a strong foundational understanding of genomics and its practical applications. 

---

For Continuing Education (CE) Credit

Click Here to Participate 

Format: Interactive recorded webinars
CE Credits Available Until: November 1, 2024  

In this activity, you will complete 3 modules to fulfill a minimum of 1.0 Nursing CE contact hour. If you complete a 4th module, you will earn 1.5 Nursing CE contact hours. You will begin by completing the 2 Foundations modules, followed by 1 interactive Clinical Applications module.  If you complete a 2nd Clinical Applications module, you will earn an additional 0.5 contact hour. 

Continuing Education Information
Nurses
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.0-1.5 continuing education contact hour(s) through the California Board of Registered Nursing.

Nurse Practitioners     

This activity is approved for 1.5 contact hour(s) of continuing education (which includes 1.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 24016477. This activity was planned in accordance with AANP Accreditation Standards and Policies.

 

For Continuing Medical Education (CME) Credit

Click Here to Participate 

If you are requesting physician credit, access individual activity information and participate by clicking the participation button above.
 

---

Target Audience

This activity is intended for hematologists, hematologists/oncologists, medical oncologists, nurses, physician assistants, and nurse practitioners who provide care for patients with blood cancers in the academic and community settings.

Learning Objectives

Upon completion of the activity, participants should be able to:

• Review genomic principles, terminology, technologies, and applications  
• Describe available genomic tests for diagnosis of hematologic malignancies and relevant premalignant conditions
• Interpret test results and select appropriate therapeutic agents to manage specific hematologic malignancies          
• Develop strategies to discuss key aspects of genomic testing with patients and caregivers

Two Foundations Modules

• Patient Points: Explaining the Importance and Implications of Testing
• Clinical Applications: Overview of Genomic Tests and Their Use in Guiding Clinical Decisions
• Glossary of Terms: A downloadable PDF document that can be used as a resource for the various types of genomic testing

Two Clinical Applications Interactive Adaptive Learning Modules

• AML/MDS Adaptive Learning Module
• Lymphoma Adaptive Learning Module

Please click here to listen to six non-accredited podcast episodes on genomics.
 

Steering Committee

Jennifer Brown, MD, PhD (Steering Committee Chair) Director, CLL Center of the Division of Hematologic Malignancies Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School Boston, MA Rafael Fonseca, MD Director, Mayo Clinic Comprehensive Cancer Center Director for Innovation and Transformational Relationships Getz Family Professor of Cancer, Distinguished Mayo Investigator Phoenix, AZ Neha Mehta-Shah, MD, MSCI Assistant Professor, Department of Medicine Division of Medical Oncology Washington University in St. Louis School of Medicine St. Louis, MO

Alice Mims, MD Acute Leukemia Clinical Research Director Assistant Professor, Division of Hematology The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus, OH Nina Fragale, NP Internal Medicine, Medical Oncology Washington University in St. Louis School of Medicine St. Louis, MO

Faculty

Rafael Fonseca, MD Director, Mayo Clinic Comprehensive Cancer Center Director for Innovation and Transformational Relationships Getz Family Professor of Cancer, Distinguished Mayo Investigator Phoenix, AZ Neha Mehta-Shah, MD, MSCI Assistant Professor, Department of Medicine Division of Medical Oncology Washington University in St. Louis School of Medicine St. Louis, MO Alice Mims, MD Acute Leukemia Clinical Research Director Assistant Professor, Division of Hematology The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus, OH Mary Albrethsen, APRN-CNP Nurse Practitioner The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute Columbus, OH

Robert Coleman Lindsley, Jr., MD, PhD Associate Professor of Medicine Dana-Farber Cancer Institute  Harvard Medical School  Boston, MA Darci L. Zblewski, APRN, CNP Nurse Practitioner Mayo Clinic Rochester, MN Ann S. LaCasce, MD, MMSc Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology Fellowship Program in Hematology/Oncology Chair Dana-Farber Cancer Institute  Associate Professor of Medicine Harvard Medical School Boston, MA

Provider Statement

This activity is provided by The Leukemia & Lymphoma Society and the American Society of Hematology, in collaboration with The France Foundation.

Supporters

This activity is supported by educational grants from AbbVie, Astellas, Daiichi Sankyo, Illumina, and Pharmacyclics.

 

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.

< Back to Continuing Education